SPOTLIGHT: Advaxis vaccine demonstrates potential


Advaxis says it is developing a vaccine that could be effective in combating cervical cancer. The company says that its vaccine has proven safe in women with advanced cervical cancer in a small trial of seven stable patients. Three of the women demonstrated a reduction of tumor mass following therapy. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.